New VitA-Pos Eye Ointment Introduced for night time use

AFT Pharmaceuticals is pleased to announce the launch of the new VitA-POS® eye ointment to the Australian market.

VitA-POS® is a smooth, preservative-free eye ointment containing Vitamin A that prevents evaporation from the ocular surface during the night.

It improves the tear film and provides valuable protection of the ocular surface during sleep for all forms and severity of dry eye. VitA-POS® is both preservative-free and phosphate-free, and contains the equivalent of 250 IU of Vitamin A per gram.

VitA-POS® eye ointment also has a use-up period of six months after opening, and more than 300 applications are possible from a 5g pack.

Find out more about VitA-POS®

July 23, 2026

Pitt St Research initiates coverage on AFT Pharmaceuticals

AFT Pharmaceuticals (NZX: AFT; ASX: AFP), today announces that Pitt St Research has initiated coverage on AFT Pharmaceuticals Ltd….

Read More

May 21, 2026

AFT delivers double digit revenue growth and record earnings

Operating profit or $24.4 million ahead of the guidance range….

Read More

May 18, 2026

AFT Pharmaceuticals names Stuart Houliston CFO

AFT Pharmaceuticals (NZX: AFT; ASX: AFP), New Zealand’s largest domestic pharmaceuticals company, today advises that Stuart Houliston will commence …

Read More